Report Description
A recent market
intelligence report that is published by Data Insights Partner on the global Prefilled
Syringe market makes an offering of in-depth analysis of segments and
sub-segments in the regional and international Prefilled
Syringe market. The research also emphasizes on the impact of restraints,
drivers, and macro indicators on the regional and global Prefilled
Syringe market over the short as well as long period of
time. A detailed presentation of forecast, trends, and dollar values of global Prefilled
Syringe market is offered. In accordance with the report,
the global
Prefilled Syringe market is projected to
expand at a CAGR of 4% over the period
of forecast.
Market Insight, Drivers, Restraints&
Opportunity of the Market:
A prefilled syringe is either disposable or reusable
syringe which is supplied to the end-user by loading the medicines for
treatment. This product can be made by glass or plastic or polymer. The global Prefilled
Syringe market is primarily driven by increasing number of arthritis, diabetes,
cardiovascular disease across worldwide. According to the World Health
Organization, the number of people with diabetes had risen from 108 Million to
422 Million, in 1980 and 2014, respectively. The global prevalence of diabetes
among adult population (18 years or older) increased from 5% to 8%, in 1980 and
2014, respectively. The prevalence of diabetes has been growing rapidly across
the low and middle income countries. The World Health Organization also
estimated that the prevalence of arthritis is more common among women rather
than men in the developed countries. The global prevalence of rheumatoid
arthritis was 0.3% to 1%- in India, around 15% of population (which interprets
180 Million) people suffer from arthritis, according to a Arthritis Foundation
India. Other factors which might
encourage the growth of the global prefilled syringe market are less overfill,
less medical error, better use of drugs, low manufacturing cost etc.
On the other hand, the risk of contamination may hamper
the growth of the global prefilled syringe market across worldwide. In August
2018, Prefilled Syringe major- BD voluntarily recalled 969 units of
PosiFlush Heparin Lock Flush prefilled
syringes and Normal Saline Prefilled Syringes from certain states of the U.S
due to a potential contamination of some end-user with Serratia marcescens
bacterium. The Foods and Drug
Administration, US and the Centers of Disease Control and Prevention (CDC)
notified BD about the epidemiological link between the catheters related blood
stream infection and Serratia marcescens bacterium. However, BD, USFDA and CDC
have been currently conducting the investigations about the contaminations and
level of adverse drug reactions.However, increasing research and development
expenditure by the major players, universities and research hospitals,
strategic alliance among the major companies, new product development may bring
the global Prefilled Syringe market an
opportunity to propel in the upcoming period.
Segment Covered:
This market
intelligence report on the global Prefilled Syringe market encompasses market
segments based on product type, therapeutic category, design and geography. On
the basis of product type, the sub-market is segmented into glass prefilled
syringe and plastic prefilled syringe. Based
on therapeutic category, the global Prefilled Syringe market has been
segregated into arthritis prefilled syringe, vaccine prefilled syringe, PCSK9
Inhibitor prefilled syringe, Insulin prefilled syringe, heparin prefilled
syringe and others. By design, the global Prefilled Syringe market is
classified into single chamber prefilled syringe, dual chamber prefilled
syringe and customized prefilled syringe. By Geography, the global Prefilled Syringe market has been divided into North America
(the U.S., Canada), Latin America (Brazil, Mexico, Argentina and other
countries), Europe (Germany, France, the U.K., Spain, Italy, Russia, and other
countries), Asia Pacific (India, Japan, China, Australia and New Zealand and
other countries), Middle East and Africa (GCC, South Africa, Israel and Other
countries).
Profiling of Market
Players:
This business
intelligence reportoffers profiling of reputed companies that are operating in
the market. Companies such as BD, Baxter International, Inc., Consort Medical,
YPSOMED, NIPRO, West Pharmaceutical Services, Inc., Wilhelm Haselmeier GmbH
& Co. KG, SHL Group, Schott AG and others have been profiled into detail so
as to offer a glimpse of the market leaders. Moreover, parameters such as Prefilled
Syringe market related investment & spending and developments by major
players of the market are tracked in this global report.
Report Highlights:
In-depth
analysis of the micro and macro indicators, market trends, and forecasts of
demand is offered by this business intelligence report. Furthermore, the report
offers a vivid pictureof the factors that are steering and restraining the
growth of this market across all geographical segments. In addition to that, IGR-Growth
Matrix analysis is alsoprovided in the report so as to share insight of the
investment areas that new or existing market players can take into consideration.
Various analytical tools such as DRO analysis, Porter's five forces analysis
has been used in this report to present a clear picture of the market. The
study focuses on the present market trends and provides market forecast from
the year 2017-2027. Emerging trends that would shape the market demand in the
years to come have been highlighted in this report. A competitive analysis in
each of the geographical segments gives an insight into market share of the
global players.
Salient Features:
Ø
This studyofferscomprehensive
yet detailed analysis of the Prefilled Syringe market, size of the market (US$ Mn), and Compound Annual Growth
Rate (CAGR (%)) for the period of forecast: 2019 – 2027, taking into account
2018 as the base year
Ø
It
explainsupcoming revenue opportunities across various market segments and
attractive matrix of investment proposition for the said market
Ø
This market
intelligence report also offers pivotal insights about various market opportunities,
restraints, drivers, launch of new products, competitive market strategies of
leading market players, emerging market trends, and regional outlook
Ø
Profiling of
key market players in the world Prefilled Syringe market is done by
taking into account various parameters such as company strategies, distribution
strategies, product portfolio, financial performance, key developments,
geographical presence, and company overview
Ø
Leading
market players covered this report comprise names such as. BD, Baxter International, Inc., Consort Medical, YPSOMED,
NIPRO, West Pharmaceutical Services, Inc., Wilhelm Haselmeier GmbH & Co. KG,
SHL Group, Schott AG and among others
Ø
The data of
this report would allow management authorities and marketers of companies alike
to take informed decision when it comes to launch of products, government
initiatives, marketing tactics and expansion, and technicalup gradation
Ø
The world
market for Prefilled Syringe market caters to the
needs of various stakeholders pertaining to this industry, namely suppliers, manufacturers,
investors, and distributors for Prefilled Syringe market. The research also caters to the rising needs of consulting
and research firms, financial analysts, and new market entrants
Ø
Research
methodologies that have been adopted for the purpose of this study have been
clearly elaborated so as to facilitate better understanding of the reports
Ø
Reports have
been made based on the guidelines as mandated by General Data Protection
Regulation
Ø
Ample number
of examples and case studies have been taken into consideration before coming
to a conclusion
Reasons to buy:
v
Identify
opportunities and plan strategies by having a strong understanding of the
investment opportunities in the Prefilled
Syringe market
v
Identification
of key factors driving investment opportunities in the Prefilled Syringe market
v
Facilitate
decision-making based on strong historic and forecast data
v
Position
yourself to gain the maximum advantage of the industry’s growth potential
v
Develop
strategies based on the latest regulatory events
v
Identify key
partners and business development avenues
v
Respond to
your competitors’ business structure, strategy and prospects
v
Identify key
strengths and weaknesses of important market participants